Lepercq De Neuflize Asset Management LLC 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Lepercq De Neuflize Asset Management LLC disclosed 14 US equity positions worth $103.3m in its Q1 2025 13F filing. The largest position was SPY at 62.4% of the reported book, followed by EFA and LFCR. Against the Q4 2024 filing, it opened 2 new positions, added to 3 and reduced 1 among the top 14 holdings.
What did Lepercq De Neuflize Asset Management LLC own in Q1 2025? Top 14 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | SPY SPDR S&P 500 ETF TR | 62.4% | $64.5m | 115,245 | 0% | held | |
| 2 | EFA ISHARES TR | 36.9% | $38.1m | 466,000 | 0% | held | |
| 3 | LFCR LIFECORE BIOMEDICAL INC | 0.1% | $138.7k | 19,700 | -13% | reduced | |
| 4 | XYLO TECHNOLOGIES LTD | 0.1% | $128.0k | 26,059 | 0% | held | |
| 5 | WETH WETOUCH TECHNOLOGY INC | 0.1% | $98.5k | 67,954 | 0% | held | |
| 6 | CLAR CLARUS CORP NEW | Consumer Cyclical | 0.1% | $83.2k | 22,200 | 6% | added |
| 7 | SQFTEUR PRESIDIO PPTY TR INC | 0.1% | $77.1k | 134,125 | 0% | held | |
| 8 | ENZB ENZO BIOCHEM INC | 0.1% | $57.8k | 156,303 | 27% | added | |
| 9 | EPIEUR ESSA PHARMA INC | 0.0% | $50.1k | 31,700 | 5% | added | |
| 10 | ANTX AN2 THERAPEUTICS INC | 0.0% | $31.6k | 23,234 | – | new | |
| 11 | LAVA THERAPEUTICS NV | 0.0% | $29.2k | 23,000 | – | new | |
| 12 | BRN BARNWELL INDS INC | 0.0% | $24.3k | 15,000 | 0% | held | |
| 13 | DSWL DESWELL INDS INC | 0.0% | $23.6k | 10,000 | 0% | held | |
| 14 | LGL LGL GROUP INC | 0.0% | $8.4k | 26,200 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.